Cargando…

Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy

BACKGROUND: Surgery remains the mainstay of therapy for pancreatic head (PH) and periampullary carcinoma (PC) and provides the only chance of cure. Improvements of surgical technique, increased surgical experience and advances in anesthesia, intensive care and parenteral nutrition have substantially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binziad, Salah, Salem, Ahmed A. S., Amira, Gamal, Mourad, Farouk, Ibrahim, Ahmed K., Manim, Tariq Mohamed Abdel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Pancreatic Cancer: Rare Variants and Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889193/ https://www.ncbi.nlm.nih.gov/pubmed/24455609 http://dx.doi.org/10.4103/2278-330X.114145

Ejemplares similares

Solid and cystic papillary neoplasm of pancreas: A clinic-pathological and immunohistochemical study: A tertiary care center experience
por: Patnayak, Rashmi, et al.
Publicado: (2013)

Cystic lesions of the pancreas: Improved understanding, diagnostics and refined outcomes
por: Sirohi, Bhawna, et al.
Publicado: (2013)

Whipple resection: The need for specialization, standardization and centralization
por: Shrikhande, Shailesh V.
Publicado: (2013)

Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center
por: van Roessel, Stijn, et al.
Publicado: (2018)

Challenges in the Study of Adjuvant Chemoradiation After Pancreaticoduodenectomy
por: Crane, Christopher H., et al.
Publicado: (2009)

Surgical Outcomes and Comparative Analysis of Transduodenal Ampullectomy and Pancreaticoduodenectomy: A Single-Center Study
por: Min, Eun-Ki, et al.
Publicado: (2021)

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
por: Navez, Julie, et al.
Publicado: (2021)

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
por: Neesse, Albrecht, et al.
Publicado: (2014)

Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial
por: Yoh, Kazunori, et al.
Publicado: (2018)

A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study
por: Ishii, Hiroshi, et al.
Publicado: (2018)

Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial
por: Yoh, Kazunori, et al.
Publicado: (2018)

Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial
por: Luo, Hao, et al.
Publicado: (2021)

Clinical impact of physical exercise on sleep disorder as assessed by actigram in patients with chronic pancreatitis: a study protocol for a randomised controlled trial
por: Yoh, Kazunori, et al.
Publicado: (2018)

Moderately severe and severe acute pancreatitis : a systematic review of the outcomes in the USA and European Union-5
por: Sarri, Grammati, et al.
Publicado: (2019)

Novel multidisciplinary hub-and-spoke tertiary service for the management of severe acute pancreatitis
por: Nayar, Manu K, et al.
Publicado: (2021)

Social deprivation does not impact on acute pancreatitis severity and mortality: a single-centre study
por: Lim, Wei Boon, et al.
Publicado: (2023)

Incidence of acute pancreatitis among patients with leptospirosis requiring extracorporeal membrane oxygenation (ECMO): a descriptive study
por: Madrigal, Tristan Paulo R, et al.
Publicado: (2023)

Discussion: Pancreatic Pathology
por: Jensen, Robert T.
Publicado: (1992)

Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
por: Augustinus, Simone, et al.
Publicado: (2023)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer
por: Van Rijssen, L. B., et al.
Publicado: (2016)

The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
por: Korrel, M., et al.
Publicado: (2020)

Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery
por: Li, Huang-bao, et al.
Publicado: (2019)

Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model
por: Latenstein, Anouk E. J., et al.
Publicado: (2020)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer
por: Holyoake, Daniel L.P., et al.
Publicado: (2016)

Treatment and Survival of Elderly Patients with Stage I–II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium
por: Groen, Jesse V., et al.
Publicado: (2020)

Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria
por: Anger, Friedrich, et al.
Publicado: (2020)

Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience
por: Del Chiaro, Marco, et al.
Publicado: (2016)

Laparoscopic Excision Versus Open Excision for the Treatment of Choledochal Cysts: A Systematic Review and Meta-Analysis
por: Zhen, Chen, et al.
Publicado: (2015)

Immunoglobulin G4–Related Sclerosing Cholangitis Mimicking Hilar Cholangiocarcinoma Diagnosed With Following Bile Duct Resection: Report of a Case
por: Miki, Atsushi, et al.
Publicado: (2015)

A Left-Sided Approach for Resection of Hepatic Caudate Lobe Hemangioma: Two Case Reports and a Literature Review
por: Feng, Xielin, et al.
Publicado: (2015)

Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry
por: Lu, Tzu-Pin, et al.
Publicado: (2021)

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
por: Hill, Colin S., et al.
Publicado: (2022)

The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer
por: Abbas, Hamza, et al.
Publicado: (2011)

EUS-guided through the needle microbiopsy: a useful adjunct in the investigation of pancreatic cystic lesions
por: Ahmed, Wafaa, et al.
Publicado: (2023)

Reclassification of the BRAF p.Ile208Val variant by case-level data sharing
por: Grant, Andrew R., et al.
Publicado: (2018)

Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data
por: Hernandez, Felicia, et al.
Publicado: (2022)

Novel PAX6 variant in a family with ophthalmologic, pancreatic, and olfactory features
por: Buehne, Kristen L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jll2bgeeqlq525kv6hhkhc504k